Cannabis use disorder: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• GLP-1 0

24 of 201 institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

No running funded project names this disease yet.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  Sex Differences in Neurobehavioral Response to THC

  NCT07225777· Medical University of South Carolina· Updated 6 Oct 2026

  “Funding status change.”Registry text, quoted unchanged. Source

• Withdrawn

  Drug-Drug Interaction Between THC and AEF0117

  NCT06395688· Aelis Farma· Updated 27 Feb 2026

  “Due to several issues, this study has never been submitted to the IRB. So the sponsor was decided to withdraw it.”Registry text, quoted unchanged. Source

• Terminated

  Understanding Effects of Cannabis Use and Abstinence on Neural Glutamate Homeostasis

  NCT05664763· Yale University· Updated 19 Aug 2025

  “Insufficient funding”Registry text, quoted unchanged. Source

• Withdrawn

  Varenicline for the Treatment of Cannabis and Tobacco Use Disorders in Veterans

  NCT05294263· VA Office of Research and Development· Updated 27 Aug 2024

  “Despite the numerous approaches below, we have not been successful in identifying a recruitment pathway that would ensure feasibility of study continuation. We have had multiple meetings with CSR\&D leadership to discuss our study progress”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Gender/Sex & CUD Remission

  NCT04964739· Medical University of South Carolina· Source

• Study of an Oral Fluid Testing Approach

  NCT06891235· Boston Children's Hospital· Source

• Semaglutide for the Treatment of Cannabis Use Disorder

  NCT07879612· Massachusetts General Hospital· Source

• Cannabis Association With Sleep Study

  NCT06982950· Oregon Health and Science University· Source

• Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use

  NCT05445180· Douglas Mental Health University Institute· Source

• Regulated Cannabis Access in Basel

  NCT05522205· Health Department of the Canton of Basel-Stadt· Source

• Applying Neuromodulation to Boost the Efficacy of Motivational Interviewing

  NCT07787572· The Mind Research Network· Source

• Developing a Telehealth + mHealth Cannabis Use Intervention for Young Adults

  NCT06661031· Boston Children's Hospital· Source

• Applying Mixed Methods to Identify Links Between PTSD Symptoms, Cannabis Use, and Functional Behaviors With Personalized Feedback Intervention Development

  NCT07721285· VA Office of Research and Development· Source

• Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder

  NCT07523633· Anders Fink-Jensen, MD, DMSci· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Mendelian Randomization Analysis 3
• Positron-Emission Tomography 1
• Magnetic Resonance Imaging 17
• Machine Learning 2
• Cohort Studies 5
• Genome-Wide Association Study 4

See which targets of this disease your abstract mentions, and go to the people working on them.